Publications Database

Jiang L. , Wang M. , Tang X. (2017)

Levetiracetam is associated with decrease in subclinical epileptiform discharges and improved cognitive functions in pediatric patients with autism spectrum disorder.

Neuropsychiatric Disease and Treatment

13 pp. 2321–2326.

Read Abstract (New Window) Read Full (New Window)

Kalra V. , Seth R. , Sapra S. (2005)

Autism: experiences in a tertiary care hospital.

Indian Journal of Pediatrics

72(3), pp. 227-230

Read Abstract (New Window)

Kobayashi R. , Murata T. (1998)

Setback phenomenon in autism and long-term prognosis.

Acta Psychiatrica Scandinavica

98(4), pp. 296-303

Read Abstract (New Window)

Kohane I. S. et al. (2012)

The co-morbidity burden of children and young adults with autism spectrum disorders.

PLoS ONE

7(4), e33224

Read Abstract (New Window) Read Full (New Window)

Kopp C. M. et al. (2008)

Behavior problems in children with tuberous sclerosis complex and parental stress.

Epilepsy and Behavior

13(3), pp. 505-510

Read Abstract (New Window)

Kossoff E. H. , Zupec-Kania B. A. , Rho J. M. (2009)

Ketogenic diets: An update for child neurologists.

Journal of Child Neurology

24(8), pp. 979-988

Read Abstract (New Window)

Kurita H. , Osada H. , Miyake Y. (2004)

External validity of childhood disintegrative disorder in comparison with autistic disorder.

Journal of Autism and Developmental Disorders

34(3), pp. 355-362.

Read Abstract (New Window)

Kurita H. et al. (2004)

Validity of childhood disintegrative disorder apart from autistic disorder with speech loss.

European Child and Adolescent Psychiatry

13(4), pp. 221-226.

Read Abstract (New Window)

Kuriyama S. et al. (2002)

Pyridoxine treatment in a subgroup of children with pervasive developmental disorders.

Developmental Medicine and Child Neurology

44 pp. 283-286

Larsson P. G. et al. (2012)

The effect of levetiracetam on focal nocturnal epileptiform activity during sleep: A placebo-controlled double-blind cross-over study.

Epilepsy and Behavior

24(1), pp. 44-48.

Read Abstract (New Window)

Levy M. et al. (2010)

Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry.

Journal of Neurosurgical Pediatrics

5(6), pp. 595-602

Read Abstract (New Window)

Lewine J. D. et al. (1999)

Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders.

Pediatrics

104(3), pp.405-418

Read Abstract (New Window)

Malow B. A. (2004)

Sleep disorders, epilepsy, and autism.

Mental Retardation and Developmental Disabilities Research Reviews

10(2), pp. 122-125

Read Abstract (New Window)

Mannion A. , Leader G. (2013)

Comorbidity in autism spectrum disorder: A literature review.

Research in Autism Spectrum Disorders

7(12), pp. 1595-1616.

Read Abstract (New Window)

Mannion A. , Leader G. (2014)

Epilepsy in autism spectrum disorder.

Research in Autism Spectrum Disorders

8(4), pp. 354-361.

Read Abstract (New Window)

Martin A. et al. (1992)

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

9(2), pp. 99-107

Read Abstract (New Window)

Matson J. L. , Neal D. (2009)

Seizures and epilepsy and their relationship to autism spectrum disorders.

Research in Autism Spectrum Disorders

pp. 999-1005

Read Abstract (New Window)

Ming X. et al. (2008)

Autism spectrum disorders: concurrent clinical disorders.

Journal of Child Neurology

23(1), pp. 6-13

Read Abstract (New Window)

Monji A. et al. (2004)

Carbamazepine may trigger new-onset epileptic seizures in an individual with autism spectrum disorders: a case report.

European Psychiatry

19(5), pp. 322-323

Read Abstract (New Window)

Mouridsen S. E. et al. (2008)

Mortality and causes of death in autism spectrum disorders: An update.

Autism

12(4), pp. 403-414.

Read Abstract (New Window)